Peer Exchange Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.
All Peer Exchange Understanding the Comorbidities: Psoriasis and Metabolic Syndrome Managing Challenges of Insomnia in Elderly Patients The Challenges and Treatment of Sickle Cell Disease Identifying Secondary Progressive Multiple Sclerosis A Review of the Treatment for Multiple Myeloma Rare Neurological Diseases: Spinal Muscular Atrophy and Huntington's Disease An Introduction of a New Class for the Treatment of Bone Health An Overview of the Value-Based Marketplace The Progression of Type 2 Diabetes and the Treatment Options to Manage It Immunotherapy in the Oncology Care Model Preventive Treatments for Migraines The Use of Biologics for the Treatment of Asthma Improved Outcomes in the Management of Hepatic Encephalopathy Expert Perspectives on Schizophrenia Treatment Approaches and Relapse Prevention Advances and Best Practices in the Utilization of Novel Agents in Metastatic Breast Cancer Oncology Stakeholders Summit, Summer 2018 Emerging Treatment for Migraine Advances in the Treatment of Hyperhidrosis Special Considerations in HIV Management Finding Value in Today's New Insulin Technology in Diabetes Care: From Prevention to Disease Management
Age-Related Macular Degeneration Treatments: Determining Appropriate Use Diabetes Therapy and Cardiovascular Outcomes: An Update Oncology Stakeholders Summit, Spring 2017 Reducing CVD Risk Through Optimal Lipid Management Oncology Stakeholders Summit, Fall 2016 Management Optimization in Atopic Dermatitis Oral Oncolytics: Exploring Challenges in Cost, Adherence, and Management Reducing Cardiovascular Mortality in Patients With Type 2 Diabetes Mellitus Oncology Stakeholders Summit, Spring 2016 Diabetes-Related Complications: A Focus on Diabetic Macular Edema Oncology Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Fall 2015 Healthcare Reform Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit, Spring 2015 Oncology Stakeholders Summit 2014 Diabetes and Obesity Management Prostate Cancer Rare Disease Neurological Disorders Immunotherapy Diabetes and Cardiometabolic Health
December 03, 2019 –
The panel discuss the studies looking at treating patients with biologics even in patients with comorbidities.
December 03, 2019 –
A review of the Plan B and Plan D insurance coverage and the products that are covered differently based on administration.
November 27, 2019 –
Key opinion leaders discuss the need to create a treatment paradigm for patients with insomnia.
November 27, 2019 –
Peter L. Salgo, MD, leads a discussion on the suvorexant study involving patients with Alzheimer disease, and its implications for the treatment of patients with insomnia.
November 26, 2019 –
Panelists discuss the impact of dosing schedules on patient adherence and preference.
November 26, 2019 –
A discussion on patient adherence and how to help improve compliance.
November 21, 2019 –
A consideration of the high-risk patient strata and the limitations on medications used in older individuals with preexisting conditions.
November 21, 2019 –
Key opinion leaders discuss the 2019 updates from the American Geriatrics Society on the Beers Criteria, and their significance in determining appropriate medications.
November 19, 2019 –
A review of the IL-23 inhibitors and their long-term and safety data.
November 19, 2019 –
The panel discusses the potential for decreased efficacy of treatment based on comorbidities. They also discuss the use of PASI score vs BSA to determine severity of disease and the need to identify responders and nonresponders to specific agents.
